Atea Pharmaceuticals, Inc. (AVIR) Total liabilities 2021–2022
Atea Pharmaceuticals, Inc. (AVIR) total liabilities at each fiscal year-end, per SEC filings.
$62.8MFY2022 · since FY2021: $315.8M → $62.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $62.8M | -80.1% |
| FY2021 | $315.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More AVIR financial trends
AVIR RevenueAVIR Net incomeAVIR Net marginAVIR Gross profitAVIR Gross marginAVIR Operating incomeAVIR Operating marginAVIR Operating cash flowAVIR Free cash flowAVIR Capital expendituresAVIR Return on equityAVIR Stock buybacksAVIR Dividends paidAVIR Total assetsAVIR Shareholders’ equityAVIR overview →